Minisymposia data will explore why cancers develop earlier, how tumors evade treatment and how AI is reshaping cancer research and immunotherapy. SESSIONS: SY17, ADT06, 3993, 6745, 4037, 1298, LB238, ...
PreludeDx ® and Quanterix Corporation (Nasdaq: QTRX) today highlighted that AidaBREASTâ„¢, the first multi-omic assay to predict both locoregional recurrence risk and radiation therapy benefit in ...